Early treatment of Campylobacter jejuni enteritis | Zendy

Myra D. Williams | Zendy; John B. Schorling | Zendy; Leah J. Barrett | Zendy; Sharon M. Dudley | Zendy; Ira Orgel | Zendy; William C. Koch | Zendy; David S. Shields | Zendy; Stephen Thorson | Zendy; Jacob A. Lohr | Zendy; Richard L. Guerrant | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early treatment of Campylobacter jejuni enteritis

Author(s) -

Myra D. Williams,

John B. Schorling,

Leah J. Barrett,

Sharon M. Dudley,

Ira Orgel,

William C. Koch,

David S. Shields,

Stephen Thorson,

Jacob A. Lohr,

Richard L. Guerrant

Publication year - 1989

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.33.2.248

Subject(s) - campylobacter jejuni , erythromycin , enteritis , diarrhea , antibiotics , medicine , sulfamethoxazole , microbiology and biotechnology , trimethoprim , abdominal pain , campylobacter , gastroenterology , biology , bacteria , genetics

The bacteriologic and clinical effects of early antibiotic treatment of Campylobacter jejuni enteritis were studied. Erythromycin rapidly eliminated C. jejuni from stools, whereas trimethoprim-sulfamethoxazole did not. Despite its bacteriologic effectiveness, erythromycin did not reduce the duration or severity of diarrhea, abdominal pain, or other symptoms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research